12411981

Source:http://linkedlifedata.com/resource/pubmed/id/12411981

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018801, umls-concept:C0031809, umls-concept:C0035647, umls-concept:C0036043, umls-concept:C0039736, umls-concept:C0205210, umls-concept:C1709630
pubmed:issue	5
pubmed:dateCreated	2002-11-4
pubmed:abstractText	Inflammatory mediators, especially tumor necrosis factor (TNF), have been implicated in heart failure (HF). Thalidomide has anti-inflammatory properties and selectively inhibits TNF. Thus far, thalidomide or thalidomide analogues have not been evaluated in patients with heart failure.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/HL-42250-10/10, http://linkedlifedata.com/resource/pubmed/grant/P50 HL-O6H, http://linkedlifedata.com/resource/pubmed/grant/R01 HL 58081-01, http://linkedlifedata.com/resource/pubmed/grant/R01 HL 61543-01
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9442138
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1071-9164
pubmed:author	pubmed-author:AgostonIldikoI, pubmed-author:BozkurtBiykemB, pubmed-author:DibbsZiad IZI, pubmed-author:MannDouglas LDL, pubmed-author:MullerGeorgeG, pubmed-author:WangFengF, pubmed-author:ZeldisJerome BJB
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	306-14
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12411981-Adult, pubmed-meshheading:12411981-Aged, pubmed-meshheading:12411981-Blood Pressure, pubmed-meshheading:12411981-Cytokines, pubmed-meshheading:12411981-Dose-Response Relationship, Drug, pubmed-meshheading:12411981-Drug Evaluation, pubmed-meshheading:12411981-Female, pubmed-meshheading:12411981-Heart Failure, pubmed-meshheading:12411981-Humans, pubmed-meshheading:12411981-Immunosuppressive Agents, pubmed-meshheading:12411981-Lipopolysaccharides, pubmed-meshheading:12411981-Male, pubmed-meshheading:12411981-Middle Aged, pubmed-meshheading:12411981-Myocytes, Cardiac, pubmed-meshheading:12411981-Quality of Life, pubmed-meshheading:12411981-Stroke Volume, pubmed-meshheading:12411981-Thalidomide, pubmed-meshheading:12411981-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure.
pubmed:affiliation	Winters Center for Heart Failure Research, Cardiology Section, Department of Medicine, Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas 77030, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't